| 0000-00-00 |
|
|
|
External link to document |
| 2017-07-20 |
1 |
Complaint |
infringement of United States Patent No. 7,943,788
(“the ’788 patent”), United States Patent No. 8,222,219 (“the…the ’219 patent”), and United States
Patent No. 8,785,403 (“the ’403 patent”) (collectively, “the patents-in-suit….S.C. § 355(b)(l), the ’788 patent, the ’219 patent, and the
’403 patent are listed in the United States… THE PATENTS-IN-SUIT
19. On May 17, 2011, the ’788 patent, titled “Glucopyranoside…the ’788 patent.
21. JNV is an exclusive sublicensee of the ’788 patent.
|
External link to document |
| 2020-02-10 |
128 |
Stipulation and Order |
it is the owner of United States Patent No. 7,943,788
(“the ’788 patent”).
WHEREAS, Sandoz has filed Abbreviated…District Court for the District of New Jersey for patent infringement based
on Sandoz’s filing of ANDA …2017
5 April 2021
3:17-cv-05319
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2020-05-28 |
166 |
Trial Brief |
disclosed in the ’117 patent
’126 patent U.S. Patent No. 6,414,126
…Example 10 Example 10 of U.S. Patent No. 6,414,126
FDA United States …788 patent, claim 22 of the
’219 patent, and claim 26 of the ’403 patent
BMS…Seiyaku Co., Ltd.
patents-in-suit U.S. Patent No. 7,943,788 (“the ’788 patent”),
… U.S. Patent No. 8,222,219 (“the ’219 patent”), and
U.S. Patent No. 8,785,403 |
External link to document |
| 2020-06-15 |
173 |
Opinion |
infringement of U.S. Patent Nos. 7,943,788 (“the ’788 patent), 8,222,219 (“the
’219 patent), and 8,785,403… (“the ’403 patent”) (collectively, “the patents-in-suit”). Compl. at ¶
10. The patents-in-suit are…
B. Local Patent Rules
Pursuant to the Local Patent Rules for the District of…Local Patent Rules. Zydus contends that the “priority date” disclosure
required by Local Patent Rule….D. Cal. July 17, 2015) (“Patent L.R. 3-1(f) particularly requires a patent holder
to assert a specific |
External link to document |
| 2020-07-27 |
185 |
Redacted Document |
the ’126 patent (U.S. Patent No. 6,414,126) was issued and assigned to
BMS. The ’126 patent disclosed…......................28
U.S. Patents
U.S. Patent No. 6,414,126.................................…Patents-in-Suit are the ’788 patent (U.S. Patent No. 7,943,788), the ’219 patent (U.S.
Patent No. 8,222,219), and… on the ’126 patent, the ’117 patent, and U.S. Patent No. 7,129,220 [“the ’220
patent”]) that 4-ethoxy…of the two patents—the ’788 Patent or the ’219 Patent—
is invalid. Here, the ’788 Patent was issued |
External link to document |
